Compounds > n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Prostatic Neoplasms

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Feng, FY; Hann, B; Melnyk, JE; Nguyen, HG; Shokat, KM; Steri, V1
Berthelot, P; Depreux, P; Hénichart, JP; Laconde, G; Pommery, N1

Other Studies

2 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Prostatic Neoplasms

ArticleYear
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells.
    Bioorganic & medicinal chemistry, 2020, 10-15, Volume: 28, Issue:20

    Topics: Alternative Splicing; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Structure-Activity Relationship; Sulfonamides; Tumor Cells, Cultured

2020
New analogues of the anticancer E7070: synthesis and pharmacology.
    Journal of enzyme inhibition and medicinal chemistry, 2003, Volume: 18, Issue:2

    Topics: Antineoplastic Agents; Cell Division; Drug Screening Assays, Antitumor; G1 Phase; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Structure-Activity Relationship; Sulfonamides; Tumor Cells, Cultured

2003